CAN PHYSICIANS WHO SIGN UP FOR A CONSULTING AGREEMENT CONTINUE TO SEE REPS UNDER THE OLD SYSTEM?
Yes. The roll-out of the new process will be gradual and negotiable and members will be consulted about the timing and manner of any changeover from the old process in full consultation with the Pharmaceutical Industry. The introduction of the new model should be collaborative rather than confrontational. It is hoped that the Pharmaceutical Industry will adopt a proactive role in this new process when it recognises the merits and logic of its objectives, its operation and the benefits which it can generate for both research-based and generic companies and their sales forces. Goodwill from the Public and the inclusion of a broad-based monitoring committee to evaluate the process going forward provides further layers of transparency and accountability to copperfasten the quality initiative that DOC-REP promotes.FURTHER QUESTIONSPlease address your query to info@doc-rep.com for immediate clarification.
